SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability NEW YORK–(BUSINESS WIRE)–An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced today that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company … [Read more…]
